PrimeMail, Prime Therapeutics' mail-service pharmacy, receives URAC Reaccreditation

"The URAC Accreditation for our mail-service pharmacy provides a seal of approval that assures our clients and members that we are committed to providing the highest level of member safety, clinical quality and operational excellence," said Duane Barnes, senior vice president of consumer delivery, Prime Therapeutics.

URAC offers the only third-party, voluntary accreditation program of this scope for pharmacy benefit management and prescription services industry. All standards are developed with input from URAC's Pharmacy Advisory Committee, which includes a wide range of stakeholders: employers, consumers, pharmacy consultants, health plans, retail pharmacy, pharmacy benefit management organizations, pharmacy professional organizations, labor and large public purchasing groups.

URAC's mail-service pharmacy standards address a range of industry practices including: organizational quality, customer service, communications, disclosure, mail drug management and pharmacy operations.

"We applaud Prime Therapeutics on achieving URAC Mail Service Pharmacy Accreditation," said Alan P. Spielman, URAC president and CEO. "In today's health care market, URAC accreditation provides a mark of distinction for organizations to demonstrate their commitment to quality health care."

To achieve Mail-Service Pharmacy Accreditation, Prime participated in a rigorous application and on-site evaluation process, culminating with a comprehensive summary, prepared by an accreditation review team, being presented to the URAC's Accreditation Committee.

Prime is also accredited in Pharmacy Benefit Management, having received accreditation by URAC in 2007.

About PrimeMail
PrimeMail, Prime Therapeutics' fully integrated mail-service pharmacy, provides safe, convenient and cost-effective home delivery of prescriptions and supports members throughout the process by providing around the clock customer service, online access to prescription information and history, new orders, transfers and refills.

Furthermore, PrimeMail helps manage total health care spend by offering employers and members generic substitutions, no dispensing fees, discounts on brand-name and generic drugs and increased adherence to essential medications through 90-day supply.

About Prime Therapeutics
At Prime Therapeutics, people are at the center of all we do and every decision we make.  As a leader in pharmacy benefit management, Prime is dedicated to making it easier for our members to obtain more affordable medicines. We leverage our unique connections to deliver programs that lead to the best health outcomes.

Prime's integrated pharmacy benefit management services include claims processing, benefit plan design, network management, clinical program consultation, rebate management, formulary administration, mail-service pharmacy and specialty pharmacy. 

Headquartered in St. Paul, Minn., Prime Therapeutics serves nearly 20 million people and is collectively owned by 13 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those Plans.  Prime has been recognized as one of the fastest-growing private companies in the nation by Inc. 5000 and as a most engaged workplace by Achievers.

For more information, visit www.primetherapeutics.com or follow @Prime_PBM on Twitter.

About URAC
URAC, an independent, nonprofit organization, promotes health care quality through its accreditation, education and measurement programs. URAC offers a wide range of quality benchmarking programs and services that keep pace with the rapid changes in the health care system and provides a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire health care industry. For more information, call (202) 216-9010, or visit www.urac.org and our Twitter and LinkedIn sites.

SOURCE Prime Therapeutics